NAUTILUS BIOTECHNOLOGY INC's ticker is NAUT and the CUSIP is 63909J108. A total of 83 filers reported holding NAUTILUS BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $790,000 | -37.1% | 372,476 | -20.2% | 0.22% | -58.2% |
| Q2 2022 | $1,255,000 | -48.3% | 466,607 | -16.5% | 0.53% | +36.3% |
| Q1 2022 | $2,426,000 | -55.4% | 559,019 | -46.7% | 0.39% | -80.4% |
| Q4 2021 | $5,438,000 | -9.2% | 1,049,721 | +7.7% | 1.98% | +30.6% |
| Q3 2021 | $5,987,000 | -34.1% | 975,000 | +8.3% | 1.51% | -53.5% |
| Q2 2021 | $9,090,000 | – | 900,000 | – | 3.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Madrona Venture Group, LLC | 6,020,770 | $30,663,000 | 4.08% |
| Ally Bridge Group (NY) LLC | 1,500,000 | $9,210,000 | 2.71% |
| AMAZON COM INC | 1,457,055 | $8,946,000 | 1.82% |
| Affinity Asset Advisors, LLC | 975,000 | $5,987,000 | 1.51% |
| Tikvah Management LLC | 708,540 | $4,350,436,000 | 1.18% |
| Perceptive Advisors | 8,911,151 | $54,714,000 | 0.80% |
| Bain Capital Life Sciences Investors, LLC | 2,000,000 | $12,280,000 | 0.76% |
| HILLMAN CO | 200,000 | $1,228,000 | 0.43% |
| SPHERA FUNDS MANAGEMENT LTD. | 800,000 | $4,912,000 | 0.41% |
| RA Capital Management | 2,436,430 | $14,960,000 | 0.21% |